KIF2C-IN-1

Artikelnummer: MCE-HY-173522
Artikelname: KIF2C-IN-1
Artikelnummer: MCE-HY-173522
Hersteller Artikelnummer: HY-173522
Alternativnummer: MCE-HY-173522-100MG,MCE-HY-173522-25MG,MCE-HY-173522-5MG,MCE-HY-173522-50MG,MCE-HY-173522-10MG
Hersteller: MedchemExpress
Kategorie: Biochemikalien
KIF2C-IN-1 (compound 7S9) is a cell-penetrating, selective KIF2C inhibitor with fluorescent properties (Ex/Em = 410/510 nm). KIF2C-IN-1 exhibits notable cytotoxicity and weak inhibitory effects on KIF2A/B. KIF2C-IN-1 prohibits the dissociation of KIF2C from microtubules. KIF2C-IN-1 inhibiting KIF2C reverses cross-resistance to microtubule-targeting agents. KIF2C-IN-1 reduces tumorigenesis in chemoresistant triple-negative breast cancer (TNBC) model in mice with the combination of Paclitaxel (HY-B0015)[1].
Molekulargewicht: 739.23
Reinheit: 98.08
Formel: C36H39ClN4O9S
Target-Kategorie: Kinesin,Microtubule/Tubulin
Anwendungsbeschreibung: MCE Product type: Reference compound